BMRN vs RILYT · P/E 40, rev $1.76B vs $1.95B cap
Biomarin Pharmaceutical Inc (BMRN) versus B. Riley Financial Inc. 6.00% Senior Notes Due 2028 (RILYT) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
B. Riley Financial Inc. 6.00% Senior Notes Due 2028 (RILYT) common stock listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
RILYT does not have a complete income-statement cache yet.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. RILYT currently screens at market cap $1.95B.
Not investment advice. Open the BMRN and RILYT stock pages for the full models.
Not investment advice.